Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) shot up 1.2% during mid-day trading on Wednesday . The company traded as high as $1.77 and last traded at $1.72. 234,594 shares traded hands during trading, a decline of 97% from the average session volume of 7,963,822 shares. The stock had previously closed at $1.70.
Silo Pharma Stock Performance
The business has a 50-day simple moving average of $1.32 and a two-hundred day simple moving average of $1.28.
Silo Pharma (NASDAQ:SILO – Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported ($0.22) earnings per share (EPS) for the quarter. Silo Pharma had a negative return on equity of 61.38% and a negative net margin of 5,255.05%. The business had revenue of $0.02 million for the quarter.
About Silo Pharma
Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.
See Also
- Five stocks we like better than Silo Pharma
- Options Trading – Understanding Strike Price
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Want to Profit on the Downtrend? Downtrends, Explained.
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Silo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
